Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-59542-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Momordica Charantia (Bitter Melon) Inhibits Primary Human Adipocyte Differentiation by Modulating Adipogenic Genes

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2010English

The Human Nucleophosmin 1 Mutation a Inhibits Myeloid Differentiation of Leukemia Cells by Modulating miR-10b

Oncotarget
Oncology
2016English

De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives

English

Thalidomide Inhibits Lipoarabinomannan-Induced Upregulation of Human Immunodeficiency Virus Expression

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Kinin B2-Receptor in Human iPSC Differentiation Into Cardiomyocytes

English

PinA Inhibits ATP Hydrolysis and Energy-Dependent Protein Degradation by Lon Protease

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Directed Differentiation of Mesendoderm Derivatives From Embryonic Stem Cells

2011English

Cyclin F-Dependent Degradation of RBPJ Inhibits IDH1R132H-mediated Tumorigenesis

Cancer Research
Cancer ResearchOncology
2018English

A Platform for Investigating Nuclear Organization and Its Changes During Human iPSC Differentiation

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy